ReviewFrontiers in pharmacology2025

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness.

Bin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.